Adverse effects of topical antiglaucoma drugs on the ocular surface

Citation
Mk. Arici et al., Adverse effects of topical antiglaucoma drugs on the ocular surface, CLIN EXP OP, 28(2), 2000, pp. 113-117
Citations number
18
Categorie Soggetti
Optalmology
Journal title
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
ISSN journal
14426404 → ACNP
Volume
28
Issue
2
Year of publication
2000
Pages
113 - 117
Database
ISI
SICI code
1442-6404(200004)28:2<113:AEOTAD>2.0.ZU;2-Q
Abstract
Purpose: This study was designed to determine the effect of long-term antig laucoma topical medication on the ocular surface; measuring basal Schirmer' s and tear break-up time tests using conjunctival impression cytology. Methods: The ocular surfaces of 30 control subjects (group 1), 24 primary o pen-angle glaucoma patients treated with 0.5% betaxolol hydrochloride (grou p 2), 27 primary open-angle glaucoma patients treated with 0.5% timolol mal eate (group 3) and 26 primary open-angle glaucoma patients treated with 0.5 % betaxolol and 1% dipivefrin hydrochloride (group 4) were evaluated. Basal Schirmer's and tear break-up time tests were measured and ocular surface c hanges were determined by impression cytology. Impression cytology specimen s of each group were graded and scored in the range 0-3 according to Nelson 's method. Results: Patients in groups 2, 3 and 4 showed statistically significant few er normal basal Schirmer's tests (wettability) and tear break-up time tests (P < 0.01). Also, the conjunctival impression cytology scores were signifi cantly higher in groups 2, 3 and 4 than in group 1 (P < 0.01). Conclusions: The conclusion was that it is possible that conjunctival surfa ce and tear film function change after the long-term use of antiglaucoma me dication.